Evaluating the Effects of Tasimelteon vs. Placebo in Treating Pediatric Insomnia

NCT06953869 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

420

Enrollment

INDUSTRY

Sponsor class

Conditions

Insomnia Disorder

Interventions

DRUG: Tasimelteon Oral Suspension
DRUG: Placebo

Sponsor

Vanda Pharmaceuticals